33714 Federal Register / Vol. 66, No. 122 / Monday, June 25, 2001 / Notices

Dated: June 13, 2001.

Richard G. Bryson,

Chief, Division of Regulatory Support.

[FR Doc. 01–15894 Filed 6–22–01; 8:45 am]

BILLING CODE 4310–05–M

DEPARTMENT OF JUSTICE

Drug Enforcement Administration

Manufacturer of Controlled

Substances; Notice of Registration

By Notice dated January 25, 2001, and

published in the Federal Register on

February 14, 2001, (66 FR 10320),

Cerilliant Corporation, 14050 Summit

Drive #121, P.O. Box 201088, Austin,

Texas 78708–0189, made application to

the Drug Enforcement Administration

(DEA) to be registered as a bulk

manufacturer of the basic classes of

controlled substances listed below:

Drug Schedule

Cathinone (1235) .......................... I

Methcathinone (1237) .................. I

N-Ethylamphetamine (1475) ........ I

N, N-Dimethylamphetamine

(1480).

I

Aminorex (1585) ........................... I

4-Methylaminorex (cis isomer)

(1590).

I

Gamma hydroxybutyric acid

(2010).

I

Methaqualone (2565) ................... I

Alpha-Ethyltryptamine (7249) ....... I

Lysergic acid diethylamide (7315) I

Tetrahydrocannabinols (7370) ..... I

Mescaline (7381) .......................... I

3,4,5-Trimethoxyamphetamine ..... I

4-Bromo-2, 5-

dimethoxyamphetamine (7390).

I

4-Bromo-2, 5-

dimethoxyphenethylamine

(7392).

I

4-Methyl-2, 5-

dimethoxyamphetamine (7395).

I

2, 5-Dimethoxyamphetamine

(7396).

I

2, 5-Dimethoxy-4-

ethylamphetamine (7399).

I

3, 4-Methylenedioxyamphetamine

(7400).

I

5-Methoxy-3, 4-

methylenedioxyamphetamine

(7401).

I

N-Hydroxy-3, 4-

methylenedioxyamphetamine

(7402).

I

3, 4-Methylenedioxy-Nethylamphetamine (7404).I

3, 4-

Methylenedioxymethamphetamine (7405).

I

4-Methoxyamphetamine (7411) ... I

Bufotenine (7433) ......................... I

Diethyltryptamine (7434) .............. I

Dimethyltryptamine (7435) ........... I

Psilocybin (7437) .......................... I

Psilocyn (7438) ............................. I

Acetyldihydrocodeine (9051) ........ I

Drug Schedule

Benzylmorphine (9052) ................ I

Codeine-N-oxide (9053) ............... I

Dihydromorphine (9145) ............... I

Heroin (9200) ............................... I

Morphine-N-oxide (9307) ............. I

Normorphine (9313) ..................... I

Pholcodine (9314) ........................ I

Acetylmethadol (9601) ................. I

Allyprodine (9602) ........................ I

Alphacetylmethadol except LevoAlphacetylmethadol (9603).I

Alphameprodine (9604) ................ I

Alphamethadol (9605) .................. I

Betacetylmethadol (9607) ............ I

Betameprodine (9608) .................. I

Betamethadol (9609) .................... I

Betaprodine (9611) ....................... I

Hydromorphinol (9627) ................. I

Noracymethadol (9633) ................ I

Norlevorphanol (9634) .................. I

Normethadone (9635) .................. I

Trimeperidine (9646) .................... I

Para-Fluorofentanyl (9812) .......... I

3-Methylfentanyl (9813) ................ I

Alpha-methylfentanyl (9814) ........ I

Acetyl-alpha-methylfentanyl

(9815).

I

Beta-hydroxyfentanyl (9830) ........ I

Beta-hydroxy-3-methylfentanyl

(9831).

I

Alpha-Methylthiofentanyl (9832) ... I

3-Methylthiofentanyl (9833) .......... I

Thiofentanyl (9835) ...................... I

Amphetamine (1100) .................... II

Methamphetamine (1105) ............ II

Phenmetrazine (1631) .................. II

Methylphenidate (1724) ................ II

Amobarbital (2125) ....................... II

Pentobarbital (2270) ..................... II

Secobarbital (2315) ...................... II

Glutethimide (2550) ...................... II

Nabilone (7379) ............................ II

1-Phenylcyclohexylamine (7460) II

Phencyclidine (7471) .................... II

1-

Piperidinocyclohexanecarbonitrile (8603).

II

Alphaprodine (9010) ..................... II

Cocaine (9041) ............................. II

Codeine (9050) ............................. II

Dihydrocodeine (9120) ................. II

Oxycodone (9143) ........................ II

Hydromorphone (9150) ................ II

Diphenoxylate (9170) ................... II

Benzoylecgonine (9180) ............... II

Ethylmorphine (9190) ................... II

Hydrocodone (9193) ..................... II

Levomethorphan (9210) ............... II

Levorphanol (9220) ...................... II

Isomethadone (9226) ................... II

Meperidine (9230) ........................ II

Methadone (9250) ........................ II

Methadone-intermediate (9254) ... II

Morphine (9300) ........................... II

Thebaine (9333) ........................... II

Levo-alphacetylmethadol (9648) .. II

Oxymorphone (9652) ................... II

Noroxymorphone (9668) .............. II

Alfentanil (9737) ........................... II

Sufentanil (9740) .......................... II

Fentanyl (9801) ............................ II

The firm plans to manufacture small

quantities of the listed controlled

substances to make deuterated and nondeuterated drug reference standards

which will be distributed to analytical

and forensic laboratories for drug testing

programs.

No comments or objections have been

received.

DEA has considered the factors in

Title 21, United States Code, Section

823(a) and determined that the

registration of Cerilliant Corporation to

manufacture the listed controlled

substances is consistent with the public

interest at this time. DEA has

investigated Cerilliant Corporation to

ensure that the company’s registration is

consistent with the public interest. This

investigation included inspection and

testing of the company’s physical

security systems, verification of the

company’s compliance with state and

local laws, and a review of the

company’s background and history.

Therefore, pursuant to 21 U.S.C. § 823

and 28 CFR §§ 0.100 and 0.104, the

Deputy Assistant Administrator, Office

of Diversion Control, hereby orders that

the application submitted by the above

firm for registration as a bulk

manufacturer of the basic classes of

controlled substances listed above is

granted.

Dated: June 4, 2001.

Laura M. Nagel,

Deputy Assistant Administrator, Office of

Diversion Control, Drug Enforcement

Administration.

[FR Doc. 01–15835 Filed 6–22–01; 8:45 am]

BILLING CODE 4410–09–M

DEPARTMENT OF JUSTICE

Drug Enforcement Administration

Importer of Controlled Substances;

Notice of Registration

By Notice dated November 8, 2000,

and published in the Federal Register

on November 28, 2000 (65 FR 70936),

and by Notice dated December 14, 2000,

and published in the Federal Register

on January 10, 2001 (66 FR 2003),

Cerilliant Corporation, 14050 Summit

Drive #121, P.O. Box 80189, Austin, TX

78708–0189, made application by

renewal to the Drug Enforcement

Administration to be registered as an

importer of the basic classes of

controlled substances listed below:

Drug Schedule

Cathinone (1235) .......................... I

Methcathinone (1237) .................. I

N-Ethylamphetamine (1475) ........ I

Gamma hydroxybutyric acid

(2010).

I

Ibogaine (7260) ............................ I